Skip to main content

dasiglucagon

Generic: DASIGLUCAGON HYDROCHLORIDE·Brand: ZEGALOGUE, ZEGALOGUE (AUTOINJECTOR), Zegalogue

dasiglucagon: 2 clinical trials tracked.

dasiglucagon evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about dasiglucagon, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Diabetes Mellitus, Type 1
Clinical Trial Registry Records (2)

A Phase 3, Randomised, Open-label, Cross-over Study to Confirm the Clinical Efficacy and Safety of Dasiglucagon Versus Glucagon for the Treatment of Severe Hypoglycaemia in Asian Adults With Type 1 Diabetes (T1D) Including an Investigation of Dasiglucagon in a Japanese Adolescent Cohort

NCT06588504Registry updated 2025-12-05·Phase 1·NVO
Completed

Primary endpoint: Adults cohort: Time to plasma glucose (PG) recovery, where PG recovery is defined as the first increase in PG of greater than or equal to (>=) 20 milligrams per decilitre (mg/dL) (1.1 millimoles per litre [mmol/L]) from baseline

InterventionalRandomizedopen38 enrolledStarted 2024-09Completion 2025-071 site · JapanNovo Nordisk A/S

Phase 3, Single-administration, Open-label Trial to Assess the Efficacy, Safety, PK, and PD of Dasiglucagon When Administered as a Rescue Therapy for Severe Hypoglycemia in Pediatric Patients Below 6 Years of Age With Type 1 Diabetes (T1D)

NCT05378672Registry updated 2025-07-20·Phase 3
Completed

Primary endpoint: Change From Baseline in Plasma Glucose Concentration at 30 Minutes After IMP Injection

Interventionalopen8 enrolledStarted 2023-05Completion 2024-122 sites · United StatesZealand Pharma